Literature DB >> 9521595

Analysis of the CFTR gene in Turkish cystic fibrosis patients: identification of three novel mutations (3172delAC, P1013L and M1028I).

T Onay1, O Topaloglu, J Zielenski, N Gokgoz, H Kayserili, Y Camcioglu, H Cokugras, N Akcakaya, M Apak, L C Tsui, B Kirdar.   

Abstract

In order to determine the spectrum of cystic fibrosis (CF) mutations in the Turkish population, a complete coding region of the cystic fibrosis transmembrane conductance regulator (CFTR) gene including exon-intron boundaries, on 122 unrelated CF chromosomes from 73 Turkish CF families was analysed by denaturing gradient gel electrophoresis and multiplex heteroduplex analysis on MDE gel matrix. In addition to 15 previously reported mutations and 12 polymorphisms, three novel mutations, namely 3172delAC, P1013L and M1028I, were detected. DeltaF508 was found to be present on 18.8% of CF chromosomes. The second most common mutation was 1677delTA, with a frequency of 7.3%, followed by G542X and 2183AA-->G mutations, with frequencies of 4.9%. These four most common mutations in Turkish CF population account for approximately 36% of mutations. This study could only detect 52.5% of disease-causing mutations in this population; 47.5% of CF alleles remain to be identified, reflecting the high molecular heterogeneity of the Turkish population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521595     DOI: 10.1007/s004390050683

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  A haplotype framework for cystic fibrosis mutations in Iran.

Authors:  Elahe Elahi; Ahmad Khodadad; Ilya Kupershmidt; Fereshteh Ghasemi; Babak Alinasab; Ramin Naghizadeh; Robert G Eason; Mahshid Amini; Mehran Esmaili; Mohammad R Esmaeili Dooki; Mohammad H Sanati; Ronald W Davis; Mostafa Ronaghi; Yvonne R Thorstenson
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  Reconstructing large regions of an ancestral mammalian genome in silico.

Authors:  Mathieu Blanchette; Eric D Green; Webb Miller; David Haussler
Journal:  Genome Res       Date:  2004-12       Impact factor: 9.043

3.  Association Between Cystic Fibrosis Severity Markers and CFTR Genotypes in Turkish Children.

Authors:  Abdurrahman Erdem Başaran; Ayşen Başaran; Dilara Fatma Kocacik Uygun; Elanur Yılmaz; Asef Moballegh; Latife Öz; Özgül Alper; Ayşen Bingöl
Journal:  Turk Thorac J       Date:  2021-11

4.  Next generation sequencing to determine the cystic fibrosis mutation spectrum in Palestinian population.

Authors:  O Essawi; M Farraj; K De Leeneer; W Steyaert; K De Pauw; A De Paepe; K Claes; T Essawi; P J Coucke
Journal:  Dis Markers       Date:  2015-01-26       Impact factor: 3.434

5.  CFTR Mutation Analysis in Western Iran: Identification of Two Novel Mutations.

Authors:  Nasibeh Karimi; Reza Alibakhshi; Shekoufeh Almasi
Journal:  J Reprod Infertil       Date:  2018 Jan-Mar

6.  Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia.

Authors:  Hanaa Hasan Banjar; Lin Tuleimat; Abdul Aziz Agha El Seoudi; Ibrahim Mogarri; Sami Alhaider; Imran Yaqoob Nizami; Talal AlMaghamsi; Sara Andulrahman Alkaf; Nabil Moghrabi
Journal:  Ann Saudi Med       Date:  2020-02-06       Impact factor: 1.526

7.  The Genetic Analysis of Cystic Fibrosis Patients With Seven Novel Mutations in the CFTR Gene in the Central Anatolian Region of Turkey.

Authors:  Murat Erdoğan; Mehmet Köse; Sevgi Pekcan; Melih Hangül; Burhan Balta; Aslıhan Kiraz; Gizem Akıncı Gönen; Ayşe Gül Zamani; Mahmut Selam Yıldırım; Tuğba Ramaslı Gürsoy; Fatih Ezgu; Tuğba Şişmanlar Eyüpoğlu; Ayse Tana Aslan
Journal:  Balkan Med J       Date:  2021-11       Impact factor: 2.021

8.  Analysis of CFTR Gene Mutations in Children with Cystic Fibrosis, First Report from North-East of Iran.

Authors:  Atieh Mehdizadeh Hakkak; Mohammad Keramatipour; Saeid Talebi; Azam Brook; Jalil Tavakol Afshari; Amin Raazi; Hamid Reza Kianifar
Journal:  Iran J Basic Med Sci       Date:  2013-08       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.